[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=e2c7bdfc8c7b648610eb1bda97a7488e0dab7bf81e09fb479352aca1b1ce897f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742229360,
      "headline": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 133220140,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=e2c7bdfc8c7b648610eb1bda97a7488e0dab7bf81e09fb479352aca1b1ce897f"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?",
    "summary": "Those who already own VRTX stock may retain it for some time to see if its CF sales continue to rise and how the Journavx and Alyftrek launch progress.",
    "url": "https://finnhub.io/api/news?id=bf9125a928b2541c92959de7eb7e6841737e2d1b2738cb443d7bcf6605981c82",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742222820,
      "headline": "Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?",
      "id": 133325413,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Those who already own VRTX stock may retain it for some time to see if its CF sales continue to rise and how the Journavx and Alyftrek launch progress.",
      "url": "https://finnhub.io/api/news?id=bf9125a928b2541c92959de7eb7e6841737e2d1b2738cb443d7bcf6605981c82"
    }
  },
  {
    "ts": null,
    "headline": "3 Unstoppable Stocks You Can Buy Now Without Any Hesitation",
    "summary": "Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility.  David Jagielski (Eli Lilly): A top pharma stock that I wouldn't hesitate to buy right now and hold for years is Eli Lilly.  There is no shortage of reasons to be bullish on the stock, as it looks poised to eventually become the first healthcare company to top a $1 trillion valuation.",
    "url": "https://finnhub.io/api/news?id=efeebbda87a3df47cb4cb72c9de4a39d5c804552a9e86c12bcd28c2300385170",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742208420,
      "headline": "3 Unstoppable Stocks You Can Buy Now Without Any Hesitation",
      "id": 133268520,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility.  David Jagielski (Eli Lilly): A top pharma stock that I wouldn't hesitate to buy right now and hold for years is Eli Lilly.  There is no shortage of reasons to be bullish on the stock, as it looks poised to eventually become the first healthcare company to top a $1 trillion valuation.",
      "url": "https://finnhub.io/api/news?id=efeebbda87a3df47cb4cb72c9de4a39d5c804552a9e86c12bcd28c2300385170"
    }
  }
]